Update June 01- June 07, 2020, Dr. Peter J. Lansberg MD, PhD Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics COVID-19 publications - Week 23 2020 899 Publications PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected] Reliable on-line resources for Covid 19 WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker AAN - Neurology resources COVID-19 resources (Harvard) COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confirmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database Mainstream Media Billionaire scientist’s COVID-19 vaccine selected for monkey tests(Science) How Iceland Beat the Coronavirus (New Yorker) Iran's rapid rise in Covid-19 cases stokes fears of the second wave (Guardian) Malaria Drug Did Not Prevent COVID Infections, Study Finds (NYT) Man Behind Sweden’s Controversial Virus Strategy Admits Mistakes (Bloomberg) Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ (Science) Surgisphere: governments suspect data from tiny US company (Guardian) Genes May Leave Some People More Vulnerable to Severe Covid-19 (NYT) The pandemic's first major research scandal erupts (Science) The Lancet has made one of the biggest retractions in modern history (Guardian) Half of Coronavirus Spread May Traced to People Without Any Symptoms (TIMES) Coronavirus crowds out other research papers (Nature index) Important Mysteries About Coronavirus Endure (NYT) The search for a COVID-19 vaccine is gaining momentum (S. Diego Union Tribune) KeyArticles 1. COVID-19: the vasculature unleashed. Nat. Rev. Immunol. 2020; Teuwen LA, Geldhof V, Pasut A, Carmeliet P. http://www.ncbi.nlm.nih.gov/pubmed/? term=32439870 2. Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV- 2? Am J Physiol Endocrinol Metab 2020; Cao X, Yin R, Albrecht H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501731 3. The role of high cholesterol in age-related COVID19 lethality. bioRxiv preprint doi: https://doi.org/10.1101/2020.05.09.086249; Hao Wang, Zixuan Yuan, Mahmud Arif Pavel, Scott B. Hansen 4. Increasing Host Cellular Receptor-Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV (or SARS- CoV-2) Infection. J Med Virol 2020; Zhuang MW, Cheng Y, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497323 5. The immune system and COVID-19: Friend or foe? Life Sci 2020:117900Yazdanpanah F, Hamblin MR, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502542 6. Endothelial cell infection and endotheliitis in COVID-19. The Lancet 2020; 395:1417-1418Varga Z, Flammer AJ, Steiger P et al. 7. Diagnostic performance of 7 rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients. Clin Microbiol Infect 2020; Van Elslande J, Houben E, Depypere M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473953 8. Approach to Acute Cardiovascular Complications in COVID-19 Infection. Circ Heart Fail 2020; Ranard LS, Fried JA, Abdalla M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500721 9. Biomarkers associated with COVID-19 disease progression. Crit. Rev. Clin. Lab. Sci. 2020:1-11Ponti G, Maccaferri M, Ruini C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503382 10. Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement from the Cardiac Society of Australia and New Zealand (CSANZ). Heart Lung Circ. 2020; Nicholls SJ, Nelson M, Astley C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473781| 11. COVID-19 Related Coagulopathy: A Distinct Entity? J Clin Med 2020; 9Marchandot B, Sattler L, Jesel L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32486469 12. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA). Vasa 2020:1-5Linnemann B, Bauersachs R, Grebe M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501145 13. Renin-Angiotensin-System (RAS) and COVID-19 - On the Prescription of RAS Blockers. Deutsche Medizinische Wochenschrift 2020; 145:682- 686Kreutz R, Abd El-Hady Algharably E, Ganten D, Messerli F. 14. Association of hypertension and antihypertensive treatment with COVID- 19 mortality: a retrospective observational study. Eur Heart J 2020; Gao C, Cai Y, Zhang K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498076 15. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020; 369:m1985Docherty AB, Harrison EM, Green CA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32444460 Basic Science (27 articles) 1. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY) 2020; 12Asselta R, Paraboschi EM, Mantovani A, Duga S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501810 2. Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 2020; Radzikowska U, Ding M, Tan G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496587 3. Related molecular mechanisms of COVID-19, hypertension, and diabetes. Am J Physiol Endocrinol Metab 2020; 318:E881Akkus E, Sahin M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479159 4. S1 Subunit and Host Proteases as Potential Therapeutic Avenues for the Treatment of COVID-19. Arch Med Res 2020; Arafah A, Ali S, Yatoo AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493626 5. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2. Arch Med Res 2020; Satarker S, Nampoothiri M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493627 6. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections. Biomed. Pharmacother. 2020; 128:110296Ghafouri-Fard S, Noroozi R, Vafaee R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480226 7. Interaction of the prototypical alpha-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex. Comput. Biol. Chem. 2020; 87:107292Liang J, Pitsillou E, Karagiannis C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485652 8. COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice. Hum Genomics 2020; 14:20Lutz C, Maher L, Lee C, Kang W. http://www.ncbi.nlm.nih.gov/pubmed/? term=32498696 9. Human Gene Sequences in SARS-CoV-2 and Other Viruses. In Vivo 2020; 34:1633-1636Lehrer S, Rheinstein PH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503822 10. SARS-CoV-2 orf1b Gene Sequence in the NTNG1 Gene on Human Chromosome 1. In Vivo 2020; 34:1629-1632Lehrer S, Rheinstein PH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503821 11. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation. Infect Genet Evol 2020:104386Dinka H, Milkesa A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473977 12. Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach. Infect Genet Evol 2020:104389Lokman SM, Rasheduzzaman MD, Salauddin A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502733 13. SARS-CoV-2 molecular and phylogenetic analysis in COVID-19 patients: A preliminary report from Iran. Infect Genet Evol 2020:104387Tabibzadeh A, Zamani F, Laali A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485332 14. A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2. Int. J. Biol. Macromol. 2020; Wang M, Fu T, Hao J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485251 15. Antiviral Effects of Probiotic metabolites on COVID-19. J Biomol Struct Dyn 2020:1-11Anwar F, Altayb HN, Al-Abbasi FA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475223 16. Virtual Screening-Driven Drug Discovery of SARS-CoV2 Enzyme Inhibitors Targeting Viral Attachment, Replication, Post-Translational Modification and Host Immunity Evasion Infection Mechanisms. J Biomol Struct Dyn 2020:1-23Quimque MTJ, Notarte KIR, Fernandez RAT et al.